NCT02424045 2018-09-06
Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma
Samsung Medical Center
Phase 2 Completed
Samsung Medical Center
SCRI Development Innovations, LLC
French Innovative Leukemia Organisation